Prognostic and predictive biomarkers for targeted therapy in NSCLC: for whom the bell tolls?-Reference-Cited by-同舟云学术

Prognostic and predictive biomarkers for targeted therapy in NSCLC: for whom the bell tolls?

Published:2015-09-11 Issue:11 Volume:15 Page:1553-1566
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Passiglia Francesco,Bronte Giuseppe,Castiglia Marta,Listì Angela,Calò Valentina,Toia Francesca,Cicero Giuseppe,Fanale Daniele,Rizzo Sergio,Bazan Viviana,Russo Antonio

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1517/14712598.2015.1071348

Reference155 articles.

1. The cancer biomarker problem

2. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies

3. Unraveling the Mystery of Prognostic and Predictive Factors in Epidermal Growth Factor Receptor Therapy

4. Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one?;Critical Reviews in Oncology/Hematology;2023-10

2. Neuromedin U contributes to radiation resistance in colorectal cancer via YAP/TAZ signaling activation;Oncology Reports;2023-08-16

3. Lung Cancer Recurrence Risk Prediction through Integrated Deep Learning Evaluation;Cancers;2022-08-27

4. Lung Cancer;Practical Medical Oncology Textbook;2021

5. Tumor Biology and Natural History;Practical Medical Oncology Textbook;2021